Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases
about
Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendationsInfections in Cancer Patients with Solid Tumors: A Review.Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.Hurdles to the Development of Effective HBV Immunotherapies and HCV VaccinesInvited Commentary: Screening for hepatitis B in the immigrant population and individuals who are in need of immunosuppressive drug therapy.Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.Hepatitis B Serology in Patients with Rheumatic DiseasesInfectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries.A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.Challenges in warranting access to prophylaxis and therapy for hepatitis B virus infection.Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching.Improvements in hepatitis B virus screening before rituximab therapy: A community-based, safety-net hospital experience.Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.Screening for viral hepatitis prior to rituximab chemotherapy.Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace.Preventing Hepatitis B Reactivation During Anti-CD20 Antibody Treatment in the Veterans Health Administration
P2860
Q26752690-7EE0622D-DE3B-4675-B2F5-EA0FC4BF5F2BQ30238576-5438C1A7-E5D8-46A1-9F2F-0C64E8AEF53CQ30248818-9DB21AD4-E163-473C-A712-18465CAE0519Q33840260-38508B07-6DD6-4C0E-B953-FCA84597557BQ36058287-8A4125EA-50CD-4B71-9C44-26BF8EBF9561Q36958944-998DA869-2669-4DF1-A044-A618A7D52286Q37291847-3B15574C-0351-4939-88A9-F2C308C4B912Q38388198-50564EE6-94DF-4FF6-8A50-3304AE13A773Q38664705-2E102C1F-88B9-46F4-9971-0FD6563940DEQ39067329-D704F356-D498-4F7F-88AD-B8AA6FE7101EQ40053236-33E8F5D5-F776-4DAC-9D8B-41CD5D4086E8Q40409921-E887FED6-D3BC-417A-8FC5-E0AA8EEA2F22Q40870495-413F93A3-96BD-46BE-A085-C7C140BF7276Q40993578-0EAE8241-42A0-4590-A26A-C44AE6904343Q47937418-5D6D2162-BDDB-4F3B-8B28-3AC92717BA5DQ58697776-CF01BB48-ECEC-4956-B737-1767C819E3BA
P2860
Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hepatitis B reactivation durin ...... or the Study of Liver Diseases
@ast
Hepatitis B reactivation durin ...... or the Study of Liver Diseases
@en
type
label
Hepatitis B reactivation durin ...... or the Study of Liver Diseases
@ast
Hepatitis B reactivation durin ...... or the Study of Liver Diseases
@en
prefLabel
Hepatitis B reactivation durin ...... or the Study of Liver Diseases
@ast
Hepatitis B reactivation durin ...... or the Study of Liver Diseases
@en
P2860
P356
P1476
Hepatitis B reactivation durin ...... or the Study of Liver Diseases
@en
P2093
R P Perrillo
P2860
P304
P356
10.1111/JVH.12305
P577
2014-09-15T00:00:00Z